Inheritest® 100 PLUS Panel
Also known as: Carrier screening, Expanded carrier testing, Pan-ethnic carrier screening
Use
This test is used for pan-ethnic carrier screening and includes analysis of more than 100 clinically relevant genetic disorders.
Special Instructions
Males are not tested for X‑linked disorders, including fragile X syndrome. Test orders must include an attestation that the provider has the patient’s informed consent for genetic testing.
Limitations
Technologies used do not detect germline mosaicism and do not rule out the presence of large chromosomal aberrations including rearrangements and gene fusions, or variants in regions or genes not included in this test, or possible inter/intragenic interactions between variants or repeat expansions. Variant classification and/or interpretation may change over time if more information becomes available. False positive or false negative results may occur for reasons that include: rare genetic variants, sex chromosome abnormalities, pseudogene interference, blood transfusions, bone marrow transplantation, somatic or tissue‑specific mosaicism, mislabeled samples or erroneous representation of family relationships. This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
8.5 mL
Minimum Volume
3 mL
Container
Yellow‑top (ACD‑A) tube or lavender‑top (EDTA) tube
Collection Instructions
Standard phlebotomy
Patient Preparation
Do not eat, drink, smoke or chew gum 30 minutes prior to collection.
Storage Instructions
Maintain specimen at room temperature or refrigerate at 4°C. Do not freeze.
Causes for Rejection
Frozen or hemolyzed specimen; quantity not sufficient for analysis; improper container or blood specimens more than four days post draw
Other tests from different labs that may be relevant